ECOG and BMI as preoperative risk factors for severe postoperative complications in ovarian cancer patients: results of a prospective study (RISC-GYN—trial)

[21] Musa F(2015)Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer Gynecol Oncol 18 896-907

[22] Dao F(2008)Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer 118 537-547

[23] Kehoe S(2011)Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly Obstet Gynecol 120 23-28

[24] Hook J(2011)Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment Gynecol Oncol 115 329-333

[25] Nankivell M(2020)Can Fried frailty score predict postoperative morbidity and mortality in gynecologic cancer surgery? Results of a prospective study J Geriatr Oncol 18 2629-2637

[26] Vergote I(2020)Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study Arch Gynecol Obstet 123 300-308

[27] Tropé CG(2009)Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events Gynecol Oncol 121 347-352

[28] Amant F(2011)Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking Ann Surg Oncol 62 451-463

[29] Zambouri A(2016)Surgical morbidity and clinical outcomes in ovarian cancer—the role of obesity BJOG 380 822-832

[30] Kumar A(2011)Wound complications after gynecologic cancer surgery Gynecol Oncol 9 26-396

[21] Musa F(2015)Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer Gynecol Oncol 18 896-907

[22] Dao F(2008)Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer 118 537-547

[23] Kehoe S(2011)Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly Obstet Gynecol 120 23-28

[24] Hook J(2011)Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment Gynecol Oncol 115 329-333

[25] Nankivell M(2020)Can Fried frailty score predict postoperative morbidity and mortality in gynecologic cancer surgery? Results of a prospective study J Geriatr Oncol 18 2629-2637

[26] Vergote I(2020)Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study Arch Gynecol Obstet 123 300-308

[27] Tropé CG(2009)Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events Gynecol Oncol 121 347-352

[28] Amant F(2011)Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking Ann Surg Oncol 62 451-463

[29] Zambouri A(2016)Surgical morbidity and clinical outcomes in ovarian cancer—the role of obesity BJOG 380 822-832

[30] Kumar A(2011)Wound complications after gynecologic cancer surgery Gynecol Oncol 9 26-396